08 Sep 2022 Governance

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement:

“We are extremely saddened to hear the news of the death of Her Majesty Queen Elizabeth II.

Together with the nation and people around the world, we remember a true leader who gave her life to duty. The Queen’s dedication, diligence and integrity were an inspiration to all and we are thankful for an inspiring monarch, who gave her life in service of her country and the Commonwealth.

The Queen’s support for the charity sector has enabled charities in the UK to thrive during her reign and will have a lasting impact for those whom the charities support. 

We share our condolences with the entire Royal Family and especially the Queen’s children and grandchildren. Our thoughts are with them at this very difficult time.” 

Related posts

Leukaemia Care and Leukaemia UK join forces with funky feathered friend to make disease symptoms more memorable

25 August 2022

Leukaemia Care and Leukaemia UK join forces with funky feathered friend to make disease symptoms more memorable

The two leading UK leukaemia charities have launched a collaboration today with a difference. They’ve joined forces with a blue and gold Macaw parrot called Henry to create an original…

A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

1 August 2022

A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for…

Leukaemia: Investigating stem cells to prevent cancer

11 January 2019

Leukaemia: Investigating stem cells to prevent cancer

Dr Alice Giustacchini, University College London and John Goldman Fellow

Clinical trial begins for pioneering new cancer treatment

10 January 2023

Clinical trial begins for pioneering new cancer treatment

Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.